Literature DB >> 9155700

Kawasaki disease, Epstein-Barr virus and coronary artery aneurysms.

G A Culora1, I E Moore.   

Abstract

AIM: To establish whether infection with Epstein-Barr virus (EBV) contributed to the development of coronary artery lesions in a six year old child with an aneurysm and stenoses of the coronary arteries and suspected Kawasaki disease.
METHODS: Postmortem paraffin wax sections of the coronary artery and myocardium were examined by in situ hybridisation for expression of EBER-1 (EBV-encoded RNA-1). Positive controls consisted of an EBV positive case of Hodgkin disease and a case of posttransplantation lymphoma.
RESULTS: No EBER-1 positive cells were identified in either myocardium or walls of the coronary artery.
CONCLUSIONS: Although EBV has been implicated in the aetiology of Kawasaki disease and development of coronary artery lesions, this process was not confirmed in this patient. It is likely that an unusual immunological reaction to a primary EBV infection with suspected deregulation of T helper cell activity leads to severe coronary artery damage in early childhood.

Entities:  

Mesh:

Year:  1997        PMID: 9155700      PMCID: PMC499744          DOI: 10.1136/jcp.50.2.161

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  Cardiac death in mucocutaneous lymph node syndrome.

Authors:  S M Kegel; T J Dorsey; M Rowen; W F Taylor
Journal:  Am J Cardiol       Date:  1977-08       Impact factor: 2.778

2.  Does Kawasaki disease have a retroviral aetiology?

Authors:  S T Shulman; A H Rowley
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

3.  Mucocutaneous lymph node syndrome in the United States.

Authors:  M E Melish; R M Hicks; E J Larson
Journal:  Am J Dis Child       Date:  1976-06

Review 4.  Acute febrile mucocutaneous lymph node syndrome.

Authors:  R Yanagihara; J K Todd
Journal:  Am J Dis Child       Date:  1980-06

5.  Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome.

Authors:  D Y Leung; E T Chu; N Wood; S Grady; R Meade; R S Geha
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

6.  Kawasaki disease and an unusual primary infection with Epstein-Barr virus.

Authors:  H Kikuta; F Mizuno; T Osato; M Konno; N Ishikawa; S Noro; N Sakurada
Journal:  Pediatrics       Date:  1984-03       Impact factor: 7.124

7.  Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome.

Authors:  D Y Leung; R C Giorno; L V Kazemi; P A Flynn; J B Busse
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

Review 8.  Kawasaki syndrome.

Authors:  A H Rowley; F Gonzalez-Crussi; S T Shulman
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

9.  Kawasaki disease: review of risk factors for coronary aneurysms.

Authors:  G Koren; S Lavi; V Rose; R Rowe
Journal:  J Pediatr       Date:  1986-03       Impact factor: 4.406

10.  The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.

Authors:  K Durongpisitkul; V J Gururaj; J M Park; C F Martin
Journal:  Pediatrics       Date:  1995-12       Impact factor: 7.124

View more
  8 in total

1.  Kawasaki disease onset during concomitant infections with varicella zoster and Epstein-Barr virus.

Authors:  Sadi Turkay; Ender Odemis; Ahmet Karadag
Journal:  J Natl Med Assoc       Date:  2006-08       Impact factor: 1.798

2.  Concomitant respiratory viral infections in children with Kawasaki disease.

Authors:  Alejandro Jordan-Villegas; Michael L Chang; Octavio Ramilo; Asunción Mejías
Journal:  Pediatr Infect Dis J       Date:  2010-08       Impact factor: 2.129

3.  Cardiovascular complications associated with chronic active Epstein-Barr virus infection.

Authors:  Jun Muneuchi; Shouichi Ohga; Masataka Ishimura; Kazuyuki Ikeda; Kenichiro Yamaguchi; Akihiko Nomura; Hidetoshi Takada; Yasunobu Abe; Toshiro Hara
Journal:  Pediatr Cardiol       Date:  2009-01-30       Impact factor: 1.655

Review 4.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

Review 5.  [Cytomegalovirus and herpes simplex virus in pathogenesis and progression of native arteriosclerosis and recurrent stenosis after intervention].

Authors:  M Herzum; J R Schaefer; G Hufnagel; B Maisch
Journal:  Herz       Date:  1998-05       Impact factor: 1.443

6.  Epidemiological and Clinical Characteristics of Kawasaki Disease and Factors Associated with Coronary Artery Abnormalities in East China: Nine Years Experience.

Authors:  Yunjia Tang; Xiang Gao; Jie Shen; Ling Sun; Wenhua Yan
Journal:  J Trop Pediatr       Date:  2016-02-15       Impact factor: 1.165

Review 7.  Kawasaki disease: what is the epidemiology telling us about the etiology?

Authors:  David Burgner; Anthony Harnden
Journal:  Int J Infect Dis       Date:  2005-07       Impact factor: 3.623

Review 8.  Infection and vasculitis.

Authors:  Cristina C Belizna; Mohamed A Hamidou; Hervé Levesque; Loic Guillevin; Yehuda Shoenfeld
Journal:  Rheumatology (Oxford)       Date:  2009-03-03       Impact factor: 7.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.